Victor Biton Selected Research

Lacosamide

12/2019	Long-term safety and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy.
11/2015	Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.
6/2012	Lacosamide for the treatment of partial-onset seizures.
6/2010	Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial.
5/2009	Long-term oral lacosamide in painful diabetic neuropathy: a two-year open-label extension trial.
11/2008	Lacosamide for the treatment of diabetic neuropathic pain.
3/2008	Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures.
7/2007	Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures.
2/2007	Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Victor Biton Research Topics

Disease

23	Seizures (Absence Seizure) 01/2022 - 02/2003
18	Epilepsy (Aura) 10/2021 - 01/2003
7	Dizziness (Lightheadedness) 12/2019 - 02/2007
5	Headache (Headaches) 12/2019 - 11/2004
3	Generalized Epilepsy 01/2016 - 11/2004
3	Nausea 11/2015 - 02/2007
3	Sleepiness 01/2014 - 02/2011
3	Peripheral Nervous System Diseases (PNS Diseases) 09/2012 - 02/2007
2	Diplopia (Double Vision) 11/2015 - 02/2011
2	Partial Epilepsies (Epilepsy, Partial) 01/2014 - 11/2004
2	Fatigue 01/2014 - 02/2011
2	Exanthema (Rash) 05/2013 - 12/2006
2	Pain (Aches) 09/2012 - 02/2007
2	Diabetic Neuropathies (Diabetic Neuropathy) 05/2009 - 02/2007
2	Neuralgia (Stump Neuralgia) 11/2008 - 11/2004
1	Rhinitis 10/2021
1	Hypersensitivity (Allergy) 10/2021
1	Nasopharyngitis 12/2019
1	Heart Failure 05/2013
1	Poisoning 05/2013
1	Chronic Pain 11/2008
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 05/2006
1	Coronary Disease (Coronary Heart Disease) 05/2006
1	Juvenile Myoclonic Epilepsy 11/2005
1	Drug Resistant Epilepsy 12/2003
1	Overweight 02/2003

Drug/Important Bio-Agent (IBA)

14	Anticonvulsants (Antiepileptic Drugs)IBA 01/2017 - 01/2003
9	Lacosamide FDA Link 12/2019 - 02/2007
8	Pharmaceutical PreparationsIBA 01/2022 - 12/2006
5	Carbamazepine (Tegretol)FDA LinkGeneric 12/2019 - 12/2006
5	Lamotrigine (Lamictal)FDA LinkGeneric 05/2013 - 02/2003
4	brivaracetamIBA 01/2022 - 01/2014
4	Valproic Acid (Depakote)FDA LinkGeneric 06/2014 - 01/2003
3	CenobamateIBA 01/2022 - 12/2021
3	Diazepam (Valium)FDA LinkGeneric 10/2021 - 01/2021
3	Nasal SpraysIBA 10/2021 - 01/2021
3	BenzodiazepinesIBA 10/2021 - 01/2021
2	Topiramate (Topamax)FDA LinkGeneric 06/2014 - 11/2005
2	Phenytoin (Dilantin)FDA LinkGeneric 06/2014 - 12/2006
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 11/2008
2	Gabapentin (Neurontin)FDA LinkGeneric 09/2012 - 02/2009
2	Zonisamide (Zonegran)FDA LinkGeneric 07/2007 - 11/2004
1	eslicarbazepine acetateIBA 01/2018
1	Pregabalin (Lyrica)FDA Link 01/2014
1	Delayed-Action PreparationsIBA 01/2014
1	Prostaglandins BIBA 01/2014
1	LigandsIBA 01/2014
1	ezogabine (retigabine)IBA 11/2013
1	Potassium Channels (Potassium Channel)IBA 08/2013
1	Adenosine Diphosphate (ADP)IBA 09/2012
1	NAD (NADH)IBA 09/2012
1	perampanelIBA 08/2012
1	AMPA Receptors (AMPA Receptor)IBA 08/2012
1	AcidsIBA 08/2012
1	rufinamide FDA Link 02/2011
1	IsoenzymesIBA 11/2008
1	Semaphorin-3AIBA 11/2008
1	Analgesics (Analgesic Drugs)IBA 11/2008
1	Sodium Channels (Sodium Channel)IBA 11/2008
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2008
1	Levetiracetam (Keppra)FDA LinkGeneric 12/2003
1	EnzymesIBA 01/2003

Therapy/Procedure

12	Therapeutics 01/2022 - 01/2003
1	Intravenous Infusions 01/2016
1	Drug Therapy (Chemotherapy) 12/2006
1	Polypharmacy 05/2006